According to the National Cancer Institute about 29,000 people a year are diagnosed with oral cancer in the United States.
Join the NYU Langone Medical Center for a discussion with Dr. Alexander Ross Kerr and Dr. Mark DeLacure on risk reduction, early detection and diagnosis, emerging research and the surgical management of oral cancer.
Dr. Mark DeLacure completed his medical training at the University of Florida College of Medicine and then went on to complete a residency in Otolaryngology (head and neck surgery) at Yale University School of Medicine and a head and neck surgery fellowship at Memorial Sloan-Kettering Cancer Center.
Dr. DeLacure is the chief of the Division of Head and Neck Surgery and Oncology and Reconstructive Head and Neck Surgery. He also serves on several committees, including New York Head and Neck Society and the Otolaryngology Head and Neck Surgery Editorial Review Board.
Alexander Ross Kerr
Dr. Ross Kerr received his doctorate in Dental Surgery from McGill University in Montreal, Canada and his MSD and certificate in Oral Medicine at the University of Washington.
He is a Diplomat of the American Board of Oral Medicine and the director of the Oral Mucosal Disease Service and the NYU College of Dentistry. Dr. Kerr is also the immediate past chair of the Oral Cancer Consortium, he is on the scientific advisory board for the Oral Cancer Foundation, and his research focus is on the evaluation of current and emerging technologies for the early detection of oral cancer and tobacco cessation in the dental practice setting.
He has lectured nationally and internationally on oral cancer and other oral medicine related topics.
Dr. Alexander Ross Kerr highlights the major risk factors for contracting oral cancer. All different forms of tobacco and alcohol have long been acknowledged high risks, but Dr. Kerr explains that diet and certain strains of the HPV virus can also play a role.